Zobrazeno 1 - 2
of 2
pro vyhledávání: '"John Brady Ridgway"'
Autor:
Minhong Yan, Jayme Franklin, Philip E. Hass, Maciej Paluch, John Brady Ridgway, Jane Ruppel, Siao Ping Tsai, Ryan Cook, Sarajane Ross, Sharon Yee, Gary Cain, Krishna P. Allamneni, Jacqueline Tarrant, Nicholas Lewin-Koh, Amrita V. Kamath, Priyanka Gupta, Christina L. Zuch de Zafra, Joseph C. Beyer, Gu Zhang, Jessica A. Couch
Supplemental Methods: including HUVEC fibrin gel bead assay, Production of anti-DLL4 F(ab')2, Mouse neonatal retina assay, Xenograft tumor models, Histological analysis of mouse liver, PK assay methods, and Anti-therapeutic antibody assay method. Tab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e3f0590c39fca49455db48a58b8d59b
https://doi.org/10.1158/1078-0432.22459589
https://doi.org/10.1158/1078-0432.22459589
Autor:
Minhong Yan, Jayme Franklin, Philip E. Hass, Maciej Paluch, John Brady Ridgway, Jane Ruppel, Siao Ping Tsai, Ryan Cook, Sarajane Ross, Sharon Yee, Gary Cain, Krishna P. Allamneni, Jacqueline Tarrant, Nicholas Lewin-Koh, Amrita V. Kamath, Priyanka Gupta, Christina L. Zuch de Zafra, Joseph C. Beyer, Gu Zhang, Jessica A. Couch
Purpose: Although agents targeting Delta-like ligand 4 (DLL4) have shown great promise for angiogenesis-based cancer therapy, findings in recent studies have raised serious safety concerns. To further evaluate the potential for therapeutic targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::285f74cb4d522ad9230ef5f64f69dc9d
https://doi.org/10.1158/1078-0432.c.6524255.v1
https://doi.org/10.1158/1078-0432.c.6524255.v1